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Background: Surgical site infection (SSI) is a common nosocomial infection in dogs and a growing concern in
veterinary hospitals as an increase in multidrug-resistant pathogens is reported. Despite the need for rational and
prudent antimicrobial use, few peer-reviewed and published veterinary studies have investigated the pathogenic
growth including susceptibility patterns of the isolated pathogens in canine SSIs.
The first objective of the present study was to estimate the distribution of bacterial pathogens in dogs with SSI and
to investigate whether this was influenced by type of surgical procedure (clean, clean-contaminated, contaminated
or dirty), duration of hospitalization, wound classification and depth of the infection, or antimicrobial treatment. The
second objective was to assess susceptibility patterns to clinically relevant antimicrobials.
During three years, four animal referral hospitals and three small animal clinics submitted bacterial swabs from
canine SSIs for culture and susceptibility, together with a questionnaire completed by the attending clinician.
Results: Approximately two thirds of the in total 194 isolates were staphylococci. Staphylococcus pseudintermedius
was the most prevalent finding (46%) followed by beta haemolytic Streptococcus spp. (24%). No associations
between distribution of the isolated pathogens and classification of the surgical procedure, duration of
hospitalization or depth of the SSI were shown, with the exception of Escherichia coli isolates being significantly
more often found in deep wound infections than in superficial skin infections.
Overall the possibilities of finding first generations antimicrobials to treat the SSIs included in the study were
favorable, as the isolated pathogens were mostly without acquired antimicrobial resistance and multidrug
resistance was uncommon. There were only three cases of methicillin-resistant S. pseudintermedius-infections
(one percent of all isolates), one case of extended-spectrum beta-lactamase producing E. coli-infection, and no
methicillin-resistant Staphylococcus aureus infections.
Conclusions: None of the investigated factors were shown to influence the distribution of bacterial pathogens. The
majority of SSIs were caused by staphylococci, and S. pseudintermedius was the most prevalent pathogen. Based on the
study results, use of first-line antimicrobials prior to receiving culture and susceptibility results is a rational empirical
antimicrobial therapy for the studied dog population.
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Surgical site infections (SSIs) has been described as a com-
plication of 0.8% to 18.1% of small animal surgical proce-
dures [1]. Postoperative infections can cause increased
patient morbidity, affect the success of initial surgical
intervention, delay healing, and in veterinary medicine
also cause additional costs for the animal owners. SSIs are
a growing concern in veterinary hospitals as an increase in
multidrug-resistant (MDR) canine pathogens is reported,
including the emergence of multidrug resistant clones of
methicillin-resistant Staphylococcus pseudintermedius in
dogs, as well as with canine methicillin-resistant Staphylo-
coccus aureus infections and Enterobacteriaceae resistant
to extended spectrum cephalosporins (ESC) [1-6].
Surgical site infections cannot be completely elimi-
nated, and preventive strategies represent the most eco-
nomical and effective means of reducing their impact.
Proper preventative measures include adherence to
aseptic principles and good surgical techniques as well
as proper preparing and caring of the dog and the surgi-
cal area prior to, during, and after surgery [1]. Develop-
ment and implementation of proper infection control
programs to prevent spread of antimicrobial resistant
bacteria through clinics and hospitals, as well as surveil-
lance protocols including patterns of antimicrobial re-
sistance have in human medicine been shown to be key
components in reducing infection rates [1,3,7]. Bacterial
culture and antimicrobial susceptibility testing of clin-
ical SSIs in veterinary practice is important for diagnosis
of bacterial growth and to guide treatment towards ra-
tional and prudent antimicrobial use. Culture-based
therapy also helps to facilitate surveillance efforts [1,8].
However, empirical treatment is often necessary, for ex-
ample before culture and susceptibility results are avail-
able or when perioperative prophylactic antimicrobial
therapy is needed.
The focus in veterinary studies on SSIs in dog has
tended to be directed towards investigating possible risk
factors for developing an infection, and few recent vet-
erinary studies have investigated the pathogenic growth,
including susceptibility patterns of the isolated patho-
gens in canine SSIs [2,8-18].
The first objective of the present study was to
estimate the distribution of bacterial pathogens in dogs
with SSI and to investigate whether this was influenced by
type of surgical procedure (clean, clean-contaminated,
contaminated or dirty as defined by the National Noso-
comial Infections Surveillance classification scheme
[7]), duration of hospitalization, wound classification
and depth of the infection, or antimicrobial treatment.
The second objective was to assess susceptibility patterns
to clinically relevant antimicrobials. Enterobacteriacae re-
sistant to extended spectrum cephalosporins, methicillin-
resistant S. pseudintermedius (MRSP), methicillin-resistantS. aureus (MRSP) and Staphylococcus schleiferi and multi-
drug resistant phenotypes were of particular interest.
The results of the study were intended to aid in asses-
sing influence of the investigated factors on bacterial
growth from SSIs in dogs in clinical practice and to pro-
vide a basis for rational empirical antimicrobial therapy,
as well as to provide a basis for future monitoring of
trends in antimicrobial resistance.
Methods
Design of the study
Four animal referral hospitals and three small animal
clinics were enrolled in the study. They were asked to
sample all detected SSIs in dogs at time of diagnosis dur-
ing three years (April 1, 2008 - April 29, 2010) and imme-
diately send the bacterial swabs by post to the National
Veterinary Institute (SVA) for culture and susceptibility
testing together with a questionnaire completed by the at-
tending clinician.
The predetermined inclusion criteria were positive bac-
terial growth from a wound infection clinically diagnosed
within a month after surgery and immediately cultured
and submitted together with a completed questionnaire.
For classification of the clinicians’ descriptions of the SSIs,
the authors used the criteria developed by The Centers for
Disease Control and Prevention National Nosocomial In-
fections Surveillance [1,7].
Data collected included surgical procedure, the date of
surgery and of bacterial sampling, name of the referring
clinic or hospital, whether the surgical site was visibly
contaminated prior to surgery or not, if contamination
during surgery was suspected, if a clinically evident in-
fection was present prior to surgery or not, duration of
hospitalization and of antimicrobial treatment, including
substances used and dates of treatment. The veterinar-
ians also subjectively described the SSI including how
the diagnosis was made and location, including depth, of
the infection.
The four referral hospitals were labelled submission cat-
egory A, B, C and D. The three animal clinics were labelled
submission category E. Two categories of hospitalization
time were defined. Isolates from dogs with SSI that spent
one day or less in the hospital or clinic were labeled
hospitalization group one. The remaining isolates were la-
beled hospitalization group two. Each dog with SSI in-
cluded in the study was defined as one case.
Based on the questionnaires, the surgical procedures
were categorized as clean, clean-contaminated, contami-
nated or dirty according to the classification scheme devel-
oped by The Centers for Disease Control and Prevention
National Nosocomial Infections Surveillance [7]. Surgical
site infections described as superficial and only involving
skin were labeled superficial skin infections, and all infec-
tions described as either deep or deep subcutaneous were
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tissue and abscesses. Two categories of antimicrobial treat-
ment were defined: treatment or no treatment. Within the
treatment group, four categories were defined depending
on whether the antimicrobial treatment was ongoing at
time of sampling or not, and whether the isolate was sus-
ceptible or not to the antimicrobial used.
Bacteriological examination
The obtained samples were inoculated and spread on
horse-blood agar (SVA, Uppsala, Sweden) and on bro-
mocresol purple lactose agar (SVA, Uppsala, Sweden) on
the day of arrival. All inoculated agar plates were incu-
bated at 37°C for 24 to 48 h until presence of adequate
growth. Identification of pathogens was based on colonyTable 1 Antimicrobial susceptibility of isolated pathogens in
Antimicrobials tes
AMP PEN
Staphylococcus pseudintermedius n = 90 BP-S ß-lact.b ß-lact.b





Staphylococcus aureus n = 15 BP-S ß-lact.b ß-lact.b





Staphylococcus schleiferi coagulans n = 7 BP-S ß-lact.b ß-lact.b





beta haemolytic Streptococcus spp. n = 47 BP-S ≤0.25 ≤0.12
% S NRd 100
MIC50 ≤1 ≤0.12
MIC90 ≤1 ≤0.12
Escherichia coli n = 20 BP-S ≤0.25 -f





Pasteurella multocida n = 6 BP-S ≤0.25 ≤0.25




Antimicrobial susceptibility presented as the percentage of susceptible isolates (%S
and 90% of the isolates respectively. Breakpoints used to define isolates as suscept
aAmpicillin (AMP), penicillin (PEN), cephalothin (CEP), oxacillin (OXA), cefotaxime (CT
(GEN), tetracycline (TET), trimethoprim- sulfamethoxazole (T-S).
bResistant to penicillin and ampicillin through beta-lactamase production (ß-lact).
cNot applicable (NA), as susceptibility is based on ß-lactamase production.
dNot relevant (NR) as breakpoints used to define isolates as susceptible (BP-S) [22] i
eNot relevant (NR) as the small number of isolates precludes calculation of MIC90.
fNot relevant (NR) as no BP-S is available.type and morphology, gram staining characteristics and
standard biochemical tests [19-21].
Antimicrobial susceptibility testing
Isolated pathogenic bacteria were tested for susceptibility
to antimicrobials relevant for the respective bacterial
species by determination of minimum inhibitory concen-
tration (MIC) by broth microdilution method using Vet-
MIC panels (SVA, Uppsala, Sweden). The classification
of susceptibility were performed using clinical break-
points (BP) according to the standards of the Clinical
and Laboratory Standards Institute (CLSI) [22] (Table 1).
In addition, staphylococci were tested for beta-lactamase
production by the “clover-leaf” method as described by
Bryan and Godfrey [23]. Escherichia coli ATCC 25922,the canine surgical site infections
teda
CEP OXA CTX ERY CLI ENR GEN TET T-S
≤2 ≤0.25 NRf ≤0.5 ≤0.5 ≤0.5 ≤2 ≤4 ≤0.5/9.5
95.6 NRd NRf 76.7 NRd 94.4 93.3 73.3 75.6
≤2 ≤0.5 NRf ≤0.5 ≤1 ≤0.12 ≤2 ≤1 ≤0.5/9.5
2 ≤0.5 NRf >4 >4 0.25 ≤2 >8 1/18
≤2 ≤2 NRf ≤0.5 ≤0.5 ≤0.5 ≤2 ≤4 ≤0.5/9.5
100 100 NRf 100 NRd 100 100 93.3 93.3
≤2 ≤0.5 NRf ≤0.5 ≤1 ≤0.12 ≤2 ≤1 ≤0.5/9.5
≤2 ≤0.5 NRf ≤0.5 ≤1 0.25 ≤2 ≤1 ≤0.5/9.5
≤2 ≤25 NRf ≤0.5 ≤0.5 ≤0.5 ≤2 ≤4 ≤0.5/9.5
100 NRd NRf 71.4 85.7 100 100 85.7 100
≤2 ≤0.5 NRf ≤0.5 ≤1 0.25 ≤2 ≤1 ≤0.5/9.5
NRe NRe NRf NRe NRe NRe NRe NRe NRe
≤2 NRf NRf ≤0.25 ≤0.5 ≤0.5 ≤2 ≤2 ≤0.5/9.5
100 NRf NRf NRd NRd 17.0 0.0 66.0 100
≤2 NRf NRf ≤0.5 ≤1 1 8 2 ≤0.5/9.5
≤2 NRf NRf ≤0.5 ≤1 2 8 >8 ≤0.5/9.5
≤2 NRf ≤1 NRf NRf ≤0.5 ≤2 ≤4 ≤0.5/9.5
5.0 NRf 95.0 NRf NRf 100 100 80.0 90.0
>4 NRf ≤0.25 NRf NRf ≤0.12 ≤2 8 ≤0.5/9.5
>4 NRf ≤0.25 NRf NRf ≤0.12 ≤2 16 ≤0.5/9.5
≤2 NRf NRf NRf NRf ≤0.5 ≤2 ≤2 ≤0.5/9.5
100 NRf NRf NRf NR f 100 100 100 100
≤2 NRf NRf 2 ≤1 ≤0.12 ≤2 ≤1 ≤0.5/9.5
NRe NRe NRf NRe NRe NRe NRe NRe NRe
) and as MIC50 and MIC90 values (mg/L), i.e. the MIC required to inhibit 50%
ible (BP-S) are according to CLSI [22].
X), erythromycin (ERY), clindamycin (CLI), enrofloxacin (ENR ), gentamicin
s below the range of concentrations tested.
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29213 and Pseudomonas aeruginosa ATCC 27853 were
used for quality control.
Isolates were classified as susceptible to an antimicrobial
according to MIC BPs for bacteria from animals issued by
CLSI [22]. Isolates of staphylococci spp. producing beta-
lactamase were classified as resistant to ampicillin and
penicillin. An isolate was classified as MDR if it was resist-
ant to three or more antimicrobial classes to which the
bacterial species is normally susceptible. For classification
of MDR in staphylococci and streptococci, ampicillin,
cephalothin and penicillin were considered as one anti-
microbial class.Genotyping
Staphylococci were tested for susceptibility to oxacillin
as indicator for methicillin resistance and isolates with
elevated MICs were examined for presence of the mecA
gene by PCR according to Strommenger et al. [24].
Moreover, E. coli and Proteus mirabilis were tested for
susceptibility to cefotaxime as indicator for resistance to
ESC. Isolates with cefotaxime MIC > 0.25 mg/L were ex-
amined for presence of genes coding for production of
extended spectrum beta-lactamases (ESBL) (gene groups
TEM, SHV, CTX-M-1, −3 and −9) or plasmid mediated
AmpC beta-lactamases (gene groups MOX, CIT, DHA,
ACC,EBC and FOX) by PCR [25-27]. Specific gene vari-
ants were determined by sequencing using in house
primers and Big-Dye™ v1.1 [28].Statistical analyses
Descriptive statistics were performed to describe the dis-
tributions of the isolated pathogens within each of the
categories of the explanatory factors as listed in Table 2.
Univariable associations were investigated between find-
ings of the isolated pathogens and the explanatory vari-
ables using Fisher’s exact-test, the χ2-test and univariable
logistic regression analysis. Moreover, for every pathogen
a multivariable logistic regression analysis was per-
formed using a manual stepwise backward variable selec-
tion procedure where the initial models included all
explanatory variables as main effects. Before inclusion in
the multivariable models the collinearity between the ex-
planatory variables was assessed pair-wise by Spearman
rank correlations. If there was collinearity (r ≥ 0.70) the
variable with lowest P-value in the univariable analysis
was selected for further modeling. All plausible two-way
interactions between the significant main effects were
tested. Variables with a significant association (P < 0.05)
with the dependent variable were kept in the model. The
model fit was evaluated with the Hosmer-Lemeshow
goodness-of-fit test and by visual examination of diag-
nostic plots as outlined by Hosmer and Lemeshow [29].For all analyses, the level of statistical significance was
set at P ≤ 0.05.
The same univariable tests described above were used
for assessment of possible associations between the ex-
planatory variables and whether more than one patho-
gen was present or not in the cultures (mixed cultures).
All statistical analyses were performed using Stata Soft-
ware (StataCorp., 2013; Stata Statistical Software: Release
13.1; College Station, TX, USA: StataCorpLP).
Results
Distribution of pathogens
In total, 157 of 203 cases of SSIs submitted during the
study period met the set inclusion criteria. The
remaining 46 samples yielded either no growth or only
insignificant non-specific growth. In 37 (23%) of the
positive cultures two pathogens were detected, leaving
in total 194 pathogenic isolates from the 157 dogs in-
cluded in the study. Eight different bacterial species
were identified in the 194 samples. Staphylococcus pseu-
dintermedius was the most prevalent finding (46%,
n = 90), followed by beta haemolytic Streptococcus spp.
(24%, n = 47), E. coli (11%, n = 21) and S. aureus (8%,
n = 15). The remaining pathogenic isolates were Staphylo-
coccus schleiferi coagulans (4%, n = 7), Pasteurella multo-
cida (3%, n = 6), P. mirabilis (2%, n = 4) and P. aeruginosa
(2%, n = 4).
An additional pathogen was identified in 66% (n = 31)
of the 47 cultures positive for beta haemolytic Strepto-
coccus spp., and in 30% (n = 27) of the 90 cultures posi-
tive for S. pseudintermedius. The two species were found
in 73% and 62%, respectively, of the 37 cultures where
two pathogens were detected. Two of the four P. mir-
abilis isolates, three of seven S. schleiferi (42%), approxi-
mately a third of the S. aureus and P. multocida isolates
(30%, n = 5 and 33% n = 2, respectively), and 19% (n = 4)
of the E. coli isolates were found in mixed cultures. It
was significantly more common to find beta haemolytic
Streptococcus spp. than S. pseudintermedius, S. aureus,
E. coli and Pseudomonas aeruginosa in mixed cultures
(P < 0.05).
Each of the four animal hospitals (A, B, C and D) sub-
mitted 11-32% of the included cases and 11-33% of the
pathogenic isolates. The three animal clinics (submission
category E) contributed with 29 cases and 32 (17%) iso-
lates (Table 2). The pathogens are presented by submis-
sion category, duration of hospitalization, wound location
and the three categories of surgical procedures in Table 2.
Six groups of surgical procedures contributed to 92% (n =
144) of the 157 cases; abdominal surgery (n = 42; 27%),
orthopaedic surgery (n = 31; 20%), mastectomy (n = 31;
20%), extirpation of subcutaneous masses (n = 23; 15%),
male dog neutering (n = 10; 6%) and traumatic injuries in-
cluding bite-wounds (n = 7; 4%).

















Percentages shown are of all
isolates (n = 194) included in
the study.
(90) 46% (47) 24% (21) 11% (15) 8% (7) 4% (6) 3% (4) 2% (4) 2%
Submission categoriesa
A (23) 12% 11 6 1 1 2 0 1 1
B (53) 27% 26 10 6 5 2 3 0 1
C (64) 33% 33 16 7 4 1 2 1 0
D (22) 11% 10 7 2 0 1 1 0 1
E (32) 17% 10 8 5 5 1 0 2 1
Hospitalization time categoriesb
≤1 day (148) 76% 68 37 16 13 6 4 2 2
≥1 day (43) 22% 20 9 5 2 1 2 2 2
Uknown (3) 2% 2 1 0 0 0 0 0 0
Locationc
Superficial skin infection (78) 40% 42 19 3 4 3 3 2 2
Deeper (116) 60% 48 28 18 11 4 3 2 2
Surgical procedure categoriesd
Clean (139) 72% 66 30 11 14 6 6 4 2
Clean- contaminated (19) 10% 9 6 3 1 0 0 0 0
Dirty (36) 18% 15 11 7 0 1 0 0 2
Antimicrobial treatment categoriese
No treatment (132) 68% 64 35 8 9 4 6 4 2
Treatment (62) 32% 26 12 13 6 3 0 0 2
The pathogens presented by the defined categories for sample origin (submission category), hospitalization time (hospitalization time category), depth of infection (location category), surgical procedures (surgical
procedure category) and whether antimicrobial treatment had been administered or not prior to sampling (antimicrobial treatment category).
aThe four enrolled referral hospitals are labeled A, B, C and D. The three animal clinics are labeled E.
bIsolates from dogs with SSI that spent one day or less in the hospital or clinic are labeled hospitalization group one. The remaining isolates are labeled hospitalization group two.
cSurgical site infections described by the attending veterinarian as superficial and only involving skin are labeled superficial skin infections, and all infections described as either deep or deep subcutaneous are labeled
deeper, as are infections including soft- or skeletal tissue and abscesses.
dThe surgical procedures are categorized as clean, clean-contaminated, contaminated or dirty according to the classification scheme developed by The Centers for Disease Control and Prevention National Nosocomial
Infections Surveillance (7).
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There were no associations between distribution of the
isolated pathogens and submission category, duration of
hospitalization or classification of the surgical procedure.
Furthermore, there were no associations between any of
the explanatory factors and whether the culture was mixed
with two pathogens or not. One significant association be-
tween isolated pathogen and depth of infection category
was found. Escherichia coli was significantly more often
found in deep wound infections than in superficial skin in-
fections compared to any other bacterial species (OR =
4.7, P = 0.02).
Antimicrobial treatment and susceptibility patterns
The majority of the isolates (68%; n = 132) were from
cases that had not received antimicrobial treatment
prior to sampling (Table 2). All of the P. multocida and
P. mirabilis isolates, approximately half of the S. schlei-
feri (n = 4) and P. aeruginosa isolates (n = 2) isolates and
two-thirds of S. aureus isolates belonged to the un-
treated group. Further statistical assessment of influence
of antimicrobial treatment on pathogenic growth was
not performed for these bacterial species due to the low
number of isolates.
Duration of treatment prior to sampling varied from
perioperative treatment during less than one day (n = 14)
to more than one week (n = 29) (Table 3). Sixty-eight per-
cent (n = 42) of the 62 isolates in the treated group were
susceptible to the antimicrobial used. Susceptibility to the
antimicrobial used could not be determined for four iso-
lates due to BPs for susceptibility being outside the range
of concentrations tested, and the results of the susceptibil-
ity testing of one of the E. coli isolates was not available.
The majority (60%; n = 9) of the 15 resistant isolates in the
treated group were E. coli (Table 3).
Seventeen percent (n = 33) of all isolates were from
cases sampled during ongoing antimicrobial treatment. Of
these, 36% (n = 12) were resistant to the respective anti-
microbial used (Table 3). Escherichia coli was significantly
more often found in samples collected during ongoing
antimicrobial treatment compared to the other pathogens
(OR = 4.7, P = 0.002).
The results from susceptibility testing of E. coli, Strepto-
coccus spp., P. multocida and staphylococci are summa-
rized in Table 1 as the percentage susceptible isolates and
as MIC50 and MIC90, i.e. the MIC required to inhibit 50%
and 90% of the isolates, respectively. For some combina-
tions of antimicrobials and bacterial species the percentage
of susceptible isolates could not be determined due to
CLSI BPs being outside of concentration ranges of the test
panels used. MIC90 was not calculated for the two species
P. multocida and S. schleiferi due to the small number of
isolates. One isolate of E. coli was not available for suscep-
tibility testing.Almost all (95%) of the 20 E. coli isolates were resistant
to cephalothin. Although the BPs for ampicillin was out-
side of concentration ranges of the test panels used, the
high ampicillin MIC50 indicates a large proportion of
ampicillin resistant isolates. The majority (80%, n = 14) of
the E. coli isolates were susceptible to the other six antimi-
crobials tested. One isolate was resistant to cefotaxime
and tetracycline and confirmed as an ESBL producer car-
rying the blaCTX-M-1 gene. No isolate had an MDR
phenotype.
All of the 47 beta-haemolytic Streptococcus spp. iso-
lates were resistant to gentamicin and 83% were resistant
to enrofloxacin (Table 1). The percentage of susceptible
isolates to ampicillin, clindamycin and erythromycin
could not be determined due to CLSI BPs being outside
of concentration ranges of the test panels used. However,
the MIC90 values for these antimicrobials are truncated
at the lowest tested concentration, which indicates that
most isolates might be susceptible. Moreover, only one
isolate had clindamycin and erythromycin MICs above
the respective BP for resistance. All isolates were suscep-
tible to penicillin and trimethoprim-sulfamethoxazole.
Sixteen isolates (34%) were either intermediate or resist-
ant to tetracycline. Disregarding enrofloxacin and genta-
micin, only one beta-haemolytic Streptococcus spp.
isolate had an MDR phenotype; the isolate was resistant
to tetracycline, clindamycin and erythromycin. The six
P. multocida isolates were susceptible to most antimi-
crobials tested but susceptibility to clindamycin and
erythromycin could not be determined as there are no
BPs for these substances.
Eighty per cent of the S. pseudintermedius isolates were
resistant to penicillin and ampicillin. Susceptibility to the
other antimicrobials varied (73–96%) (Table 1). Twenty-
six percent (n = 23) were MDR. Of these, 17 were resistant
to penicillin, erythromycin and clindamycin in addition to
other antimicrobials. Four isolates had oxacillin MIC >
0.5 mg/L indicating methicillin resistance and in three of
these the mecA gene was identified. The three isolates
were from dogs treated at three different clinics. The
methicillin-resistant isolates were all resistant to enroflox-
acin, erythromycin, clindamycin and trimethoprim-
sulphamethoxazole in addition to beta-lactam resistance.
Most (80%) of the 15 S. aureus isolates were resistant to
penicillin and ampicillin, one of which was in addition re-
sistant to tetracycline (Table 1). No S. aureus isolate was
MDR. All S. aureus isolates had oxacillin MICs < 0.5 mg/L.
Two of the seven S. schleiferi coagulans isolates were
MDR. All seven isolates had oxacillin MICs < 0.5 mg/L
(Table 1). The percentage of staphylococcus isolates suscep-
tible to ampicillin, amoxicillin-clavulanic acid and clindamy-
cin could not be determined due to CLSI BPs being outside
of concentration ranges of the test panels used. However, as
the staphylococci were resistant to penicillin and ampicillin
Table 3 Isolated pathogens presented by antimicrobial treatment
Antimicrobial
treatment (n)
Susceptibility to the antimicrobial
used (n)
Duration of treatment (n) Isolates from cases


















Staphylococcus pseudintermedius (64) (26) (20) (5) (1) (5) (5) (16) (13) (10) (3) (0)
beta haemolytic Streptococcus
spp.
(35) (12) (12) (0) (0) (2) (3) (7) (8) (8) (0) (0)
Escherichia coli (8) (13) (1) (9) (3) (0) (9) (4) (9) (0) (8) (1)
Staphylococcus aureus (9) (6) (6) (0) (0) (6) (0) (0) (0) (0) (0) (0)
Staphylococcus schleiferi (4) (3) (2) (1) (0) (1) (1) (1) (1) (0) (1) (0)
Pasteurella multocida (6) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Proteus mirabilis (4) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0) (0)
Pseudomonas aeruginosa (2) (2) (1) (0) (1) (0) (1) (1) (2) (1) (0) (1)
No. of isolates, percentages in
brackets
(132) 68%a (62) 32%a (42) 68%b (15) 24%b (5) 8%b (14) 22%b (19) 31%b (29) 47%b (33) 17%a (19) 58%c (12) 36%c (2) 6%c
Isolated pathogens presented by antimicrobial treatment; no treatment or treatment administered, susceptibility or resistance of respective isolate to the antimicrobial used, duration of treatment and whether
treatment was ongoing at time of sampling or not.
aPercentage of all of the 194 pathogenic isolates included in the study.
bPercentage of the 62 isolates from dogs that had received antimicrobial treatment prior to sampling.












Windahl et al. Acta Veterinaria Scandinavica  (2015) 57:11 Page 8 of 10through beta-lactamase production, amoxicillin-clavulanic
acid would most likely be a relevant antimicrobial for the
isolates susceptible to cephalothin (96% of the S. pseudinter-
medius isolates, 100% of the S. aureus and S. schleiferi coa-
gulans isolates respectively).
The four P. aeruginosa isolates were all susceptible to
gentamicin (MIC ≤2 mg/L). Breakpoints are not available
for the other antimicrobials tested. However,except for
enrofloxacin where all four isolates had MIC 1 mg/L, MICs
were high and mostly above the range of concentrations
tested (Table 1). Breakpoints for susceptibility are largely
lacking also for P. mirabilis but MICs for trimethoprim-
sulphamethoxazole, gentamicin and enrofloxacin were low
in all four isolates, ≤ 0.5/9.5, ≤ 2 and ≤ 0.12-0.25 mg/L, re-
spectively. Moreover, three of the isolates had ampicillin
MICs ≤1 mg/L. For the other antimicrobials tested MICs
for were high and mostly above the range of concentrations
tested (Table 1).
Discussion
The eight bacterial species isolated in this study are known
opportunistic pathogens that can be found both in healthy
dogs as part of the normal skin microbiota and in various
canine infections, including SSIs [1,3,30-32]. Fifty-eight per-
cent of the 194 isolates were coagulase- positive staphylo-
cocci, all recognized as important pathogens in canine
dermatitis and SSIs. The most prevalent finding, S. pseudin-
termedius, is considered to be the primary cutaneous patho-
gen of dogs and a well-known cause of postoperative wound
infections in dogs [30,31,33,34].
In humans, the patients’ endogenous flora is the major
source of bacteria infecting surgical wounds [1-3]. The en-
dogenous skin flora is also recognized as an important
cause of SSI in dogs, as aseptic preparation of the skin
cannot completely eliminate skin-associated bacteria, es-
pecially not bacteria residing in the deeper parts of the
skin such as the hair follicles and sebaceous glands. Both
superficial and deeper infection can be the result, as the
bacteria can enter deeper tissues during the initial incision
[1-3,7]. All the bacteria cultured in the study, including
those less commonly associated with skin disease and skin
carriage than staphylococci, might be endogenous flora re-
cently transferred to the skin at the incision site through
the dogs grooming behaviour, or through contamination
of affected tissues during surgery [1,7,30,35].
The different bacterial species causing the SSIs might
also be exogenous microorganisms transferred from the
environment. The frequency of exogenous versus en-
dogenous flora causing SSIs on dogs is not well described
[1,2,7,15]. The risk of nosocomial infections with canine
opportunistic pathogens transmitted through animal
clinics and hospitals has however been highlighted lately,
particularly with the increase in antimicrobial resistant ca-
nine infections and the emergence of multidrug resistantclones MRSP, as well as with MRSA infections and ESC-
resistant Enterobacteriaceae [36]. Exogenous sources of
surgical contamination include the surgical equipment,
the physical environment and bacteria on hands and
clothes of personnel [1,35,37,38]. Outbreaks of MRSP in-
fections have also been attributed to carriage of the organ-
ism in the nasal passages of clinicians and hospital
workers [39]. Nosocomial pathogens have been shown to
persist in the hospital environment in various locations
and bacterial colonization of human hospital patients by
endemic hospital organisms has been shown to occur in
patients within a few days of hospitalization [35,39,40].
Due to the possibility of prolonged contact with the
microbiota in the healthcare environment influencing
pathogenic growth, duration of hospitalization as well as
submission category was included in the present study,
but no influence on distribution of the eight bacterial spe-
cies was shown.
When evaluating SSIs an objective definition is desirable,
also for facilitating comparison of veterinary studies, where
various definitions have been used for postoperative SSI in
different studies [2]. A standard classification of the wounds
such as superficial incisional, deep incisional or organ/space
was however deemed not appropriate for the present study
as, with the exception of the infections classified as superfi-
cial, the information attained from the attending veterinar-
ians was decided not to be rigorous enough. Infections
including soft- or skeletal tissue or infections in the form of
an abscess could have been classified as deep incisional, but
as only seven isolates originated from this category with
four bacterial species represented, the use of only the two
terms superficial skin infection and deeper infection was
deemed more stringent.
The National Nosocomial Infections Surveillance criteria
[7] were developed for surveillance of SSIs in humans, and
although a clear correlation between the four categories of
surgical procedures and SSI rates has been reported in hu-
man medicine, it is not possible to determine either the risk
of SSI to develop or the source of the bacteria causing the
SSIs solely based on which category the surgery belongs to
[2,3]. However, the risk of an SSI being caused by an infect-
ing agent already present prior to surgery is increased in the
dirty category, to which 18% of the 194 isolates belonged.
Furthermore, the risk of the SSI being caused by endogen-
ous flora from the gastrointestinal, genitourinary or respira-
tory tracts can be expected to be decreased in the clean
category, to which 72% of the isolates belonged as proce-
dures where these body sites are opened are not included in
the clean category. No such correlations were however
found in the present study. The only significant association
between distribution of the isolated pathogen and the inves-
tigated explanatory factors was between growth of E. coli
and depth of infection as well as with antimicrobial
treatment during time of sampling. The reasons for these
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cluding critical factors such as adherence to aseptic princi-
ples and proper aseptic preparation and postoperative care
in veterinary care facilities as well as in the home environ-
ment, complicates studies like this and further studies on as-
sociations between individual bacterial species causing SSIs
and factors that can influence this are warranted.
The selection of antimicrobials for treatment of SSIs
should be based on bacterial culture and susceptibility
testing, particularly as SSIs and other nosocomial infec-
tions are increasingly complicated by the emergence of
MDR pathogens in veterinary medicine. Susceptibility
testing is a corner stone of efficient and prudent use of
antimicrobials, an important step in reducing the emer-
gence of antimicrobial resistance. Empirical treatment is
however often necessary before culture and sensitivity
results are available, and further studies on susceptibil-
ity patterns in nosocomial infections on dogs such as
SSIs are warranted, to provide a basis for both empirical
treatment and surveillance of local and general in-
creases or decreases in the overall burden of MDR path-
ogens [1,2,8]. The isolates included in the present study
are from both referral hospitals and smaller clinics. The
enrollment of several hospitals and clinics reduces the
risk of overrepresentation of the resident house flora,
including susceptibility patterns, of any individual care
facility. It has previously been stated that, as referral
hospitals are more likely to have a higher caseload of
complicated cases in need of prolonged antimicrobial
treatment, less susceptible isolates should be expected
in samples originating from referral hospitals compared
to smaller clinics [3,41-44]. Associations between anti-
microbial treatment and isolating resistant bacteria
from SSIs are beyond the scope of this study, and statis-
tical assessments of trends was not possible due to too
few resistant isolates originating from cases treated for
longer than one day.
Overall the results of the susceptibility testing were
favourable in comparison to other studies [4,37,45-49].
The isolated pathogens were mostly without acquired
antimicrobial resistance and MDR was uncommon, with
the exception of staphylococci. A majority of the staphylo-
cocci isolates were resistant to penicillin and ampicillin
and approximately one-fourth (26%) of all S. pseudinter-
medius isolates were MDR. Methicillin-resistant staphylo-
cocci such as MRSP and MRSA are globally reported as
important causes of clinical infections, including SSIs, in
dogs [3,4]. Despite a documented clonal spread of MRSP
in Europe and the increasing clinical importance of the
pathogen, MRSP was a rare finding in the nosocomial in-
fections investigated in the present study [6,50].
The emergence of ESC- resistant Enterobacteriaceae in
dogs not only complicates therapy in dogs, it is also a pub-
lic health concern when the pathogens are zoonotic or thelocation of the resistance genes enables transfer between
bacteria of animal and human origin [36,51]. In the present
study one of 20 E. coli isolates tested carried transferable
genes conferring ESC resistance by ESBL production. The
small number of isolates tested precludes conclusions on
prevalence but the finding supports vigilance towards ESC-
resistance in the investigated dog population.
Conclusions
Staphylococcus pseudintermedius was the most frequent
pathogen identified in the study (46% of all isolates), and ap-
proximately two-thirds of all isolates were staphylococci.
Escherichia coli isolates were significantly more often found
in deep wound infections than in superficial infections. No
other associations were found between the distribution of
pathogens and the included explanatory factors.
Overall the possibilities of finding first line antimicro-
bials to treat SSIs were favorable. Except for staphylococci
the isolated pathogens were mostly without acquired
resistance and MDR was uncommon. As resistance in sta-
phyloccci to penicillin and ampicillin was through beta-
lactamase production, the isolates were accordingly mostly
susceptible to first generation cephalosporins and most
likely also to a combination of amoxicillin and clavulanic
acid although this was not tested.
There were only three cases of MRSP infections (one
percent of all isolates), one case of ESBL producing E.
coli, and no MRSA infections.
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